Analysis of Vaccine-Induced Adaptive Immune Responses
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Innate and Adaptive Immunity in Vaccination".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 213
Special Issue Editors
Interests: vaccine development; viral infections; immune responses; immunosenescence; immunometabolism
Special Issues, Collections and Topics in MDPI journals
Interests: vaccine development; viral infections; immune responses
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
B and T cells play key roles in adaptive immune responses. Research into cellular immunology provides an understanding of T cell recognition, activation and dysregulation, and their roles in protecting against infectious diseases and cancer and autoimmune diseases. Similarly, studies in the field of humoral immunity are crucial to determine the roles of antibodies in providing such protection, the functionality of different immunoglobulins, and the activity of distinct B cell subsets.
In recent years, new sophisticated and cutting-edge methodologies have become available, allowing us to gain insights into lymphocyte biology and functions and their mechanisms of action. These innovative techniques can represent extremely useful tools to characterize vaccine-induced cellular and humoral responses.
This Special Issue will focus on the advances and application of these new methodologies in studying cellular and humoral immunity against vaccine-preventable infectious diseases. We request original comprehensive research articles and reviews on this topic, which must be focused on the keywords reported below and explain how these studies have changed or enhanced our understanding of T cell immunity.
Dr. Francesco Nicoli
Prof. Dr. Antonella Caputo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- RNA sequencing
- flow cytometry
- microscopy
- T cells
- B cells
- antibodies
- biochemistry
- molecular biology
- systems biology
- epitope prediction
